Published in J Hepatol on March 01, 1997
Perihepatic lymphadenopathy and the response to therapy in chronic hepatitis C patients(). J Ultrasound (2010) 0.93
Perihepatic lymphadenopathy in children with chronic viral hepatitis. J Ultrason (2015) 0.92
Chronic hepatitis B: Enlarged perihepatic lymph nodes correlated with hepatic histopathology. World J Radiol (2013) 0.83
Perihepatic lymph node enlargement is a negative predictor of liver cancer development in chronic hepatitis C patients. J Gastroenterol (2012) 0.76
Perihepatic nodes detected by point-of-care ultrasound in acute hepatitis and acute-on-chronic liver disease. World J Gastroenterol (2015) 0.75
Clinical significance of perihepatic lymphadenopathy in patients with chronic hepatitis C infection. Dig Dis Sci (2011) 0.75
Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes (2001) 9.67
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol (1999) 9.11
UV- and midwave-sensitive cone-driven retinal responses of the mouse: a possible phenotype for coexpression of cone photopigments. J Neurosci (1999) 2.79
Aberrant expression of HLA-DR antigens on bileduct epithelium in primary biliary cirrhosis: relevance to pathogenesis. Lancet (1984) 2.38
Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach. Dig Liver Dis (2006) 2.24
Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile. Hepatology (1997) 2.21
A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis. Arthritis Rheum (2012) 1.96
Comprehensive molecular cytogenetic analysis of the human blastocyst stage. Hum Reprod (2008) 1.57
Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane. Gut (2000) 1.53
Characterization of the microsomal antigen related to a subclass of active chronic hepatitis. Immunology (1974) 1.50
Prevalence of silent coeliac disease in atopics. Dig Liver Dis (2000) 1.48
Desmin and actin in the identification of Ito cells and in monitoring their evolution to myofibroblasts in experimental liver fibrosis. Virchows Arch B Cell Pathol Incl Mol Pathol (1988) 1.47
Maternal age, morphology, development and chromosome abnormalities in over 6000 cleavage-stage embryos. Reprod Biomed Online (2007) 1.47
Abdominal lymphadenopathy detected by ultrasonography in HIV-1 infection: prevalence and significance. Scand J Infect Dis (1993) 1.44
Anti tissue transglutaminase antibodies as predictors of silent coeliac disease in patients with hypertransaminasaemia of unknown origin. Dig Liver Dis (2001) 1.44
Bile duct cell apoptosis is a rare event in primary biliary cirrhosis. Dig Liver Dis (2001) 1.40
IgA antibodies to endomysium, gliadin, and reticulin in silent coeliac disease. Lancet (1992) 1.40
Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity. Lancet (1991) 1.38
Thyroid function in systemic sclerosis. J Endocrinol Invest (1991) 1.38
High prevalence of celiac disease in Italian general population. Dig Dis Sci (2001) 1.34
Frequency and significance of anti-gliadin and anti-endomysial antibodies in autoimmune hepatitis. Dig Dis Sci (1998) 1.34
Coeliac disease hidden by cryptogenic hypertransaminasaemia. Lancet (1998) 1.33
[Outbreak of Ebola hemorrhagic fever in the Republic of the Congo, 2003: a new strategy?]. Med Trop (Mars) (2003) 1.32
Type 2 autoimmune hepatitis and hepatitis C virus infection. Lancet (1990) 1.30
Antibodies to gliadin detected by immunofluorescence and a micro-ELISA method: markers of active childhood and adult coeliac disease. Gut (1985) 1.28
Immunomorphological characterisation of antinuclear antibodies in chronic liver disease. J Clin Pathol (1985) 1.23
HCV and autoimmunity. Curr Pharm Des (2008) 1.22
Basement membrane production by hepatocytes in chronic liver disease. Hepatology (1985) 1.21
Mitochondrial antibodies in primary biliary cirrhosis. V. Ultrastructural localization of the antigen to the inner mitochondrial membrane using a direct peroxidase conjugate. Br J Exp Pathol (1973) 1.20
IgA antiendomysial antibody test. A step forward in celiac disease screening. Dig Dis Sci (1991) 1.16
Evaluation of serum rosette inhibitory factors in chronic liver disease. Clin Exp Immunol (1983) 1.14
Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis. Hepatology (1996) 1.13
Quantitation of hepatitis C virus genome molecules in plasma samples. J Clin Microbiol (1994) 1.12
Characterization and isolation of ductular cells coexpressing neural cell adhesion molecule and Bcl-2 from primary cholangiopathies and ductal plate malformations. Am J Pathol (2000) 1.11
Correlation between conventional disease activity measures in juvenile chronic arthritis. Ann Rheum Dis (1997) 1.10
Ultrastructural localization and characterization of a ribosomal antibody detected by immunofluorescence in systemic lupus erythematosus. Clin Exp Immunol (1974) 1.10
Expression of co-stimulatory molecules by Kupffer cells in chronic hepatitis of hepatitis C virus etiology. Hepatology (1998) 1.09
Ito cell heterogeneity: desmin-negative Ito cells in normal rat liver. Hepatology (1994) 1.09
Dimethylnitrosamine-induced cirrhosis. Evidence for an immunological mechanism. J Hepatol (1989) 1.06
Risk of desmoid tumours after open and laparoscopic colectomy in patients with familial adenomatous polyposis. Br J Surg (2014) 1.04
Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases. Clin Exp Immunol (2003) 1.04
Anti-nuclear antibodies of primary biliary cirrhosis recognize 78-92-kD and 96-100-kD proteins of nuclear bodies. Clin Exp Immunol (1991) 1.04
Serological screening for coeliac disease in vitiligo and alopecia areata. Br J Dermatol (1997) 1.03
Construction of a continent perineal colostomy by using electrostimulated gracilis muscles after abdominoperineal resection: personal technique and experience with 32 cases. Ital J Surg Sci (1987) 1.03
Association of serum IgA and C4 with severe atherosclerosis. Atherosclerosis (1988) 1.02
Clinical findings and anti-neuronal antibodies in coeliac disease with neurological disorders. Scand J Gastroenterol (2002) 1.02
Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease. Gut (1995) 1.02
Testing for hepatitis C virus sequences in peripheral blood mononuclear cells of patients with chronic hepatitis C in the absence of serum hepatitis C virus RNA. Liver (1994) 1.02
Anti-cyclic citrullinated peptide positivity in non-rheumatoid arthritis disease samples: citrulline-dependent or not? Ann Rheum Dis (2006) 1.01
Hepatitis C viraemia in adults with type 2 autoimmune hepatitis. J Med Virol (1991) 1.01
Non-organ specific autoantibodies in children with chronic hepatitis C. J Hepatol (1996) 1.01
Quantification of hepatitis C virus-infected peripheral blood mononuclear cells by in situ reverse transcriptase-polymerase chain reaction. Blood (1996) 1.01
Maxillary sinus floor elevation for implant placement with demineralized freeze-dried bone and bovine bone (Bio-Oss): a clinical study of 20 patients. Int J Periodontics Restorative Dent (1997) 1.01
Anti-Saccharomyces cerevisiae and perinuclear anti-neutrophil cytoplasmic antibodies in coeliac disease before and after gluten-free diet. Aliment Pharmacol Ther (2005) 1.00